Is the Hikma Pharmaceuticals dividend safe?
At risk
Hikma Pharmaceuticals pays 4.1% a year, but that takes 155% of its free cash flow.
The numbers behind it
Dividend yield4.1%
Paid out of free cash flow155%
Paid out of profit46%
Debt in years of earnings1.6 years
How we decide
We look at how much of its free cash flow a company hands out. Under 60% leaves room, 60% to 90% is tight, and above 90% or heavy debt puts the dividend at risk.
More questions about Hikma Pharmaceuticals
Data as of Nov 13, 2026.